Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence…
Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent…
Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA…
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery…
PALO ALTO, CA / ACCESS Newswire / October 23, 2025 / Bioz, Inc., the industry-standard AI citation solution built to…
"The ex-New Jersey Attorney General and former DEA Administrator promised to modernize justice through data. Instead, under her watch, illegal…
The following is a corrected version of the Oct. 21, 2025, press release, MDaudit Spotlights the Vital Role of Health…
Based on a Black Book Research flash survey of 97 HIM leaders conducted at AHIMA 2025 last week. MINNEAPOLIS, MN…
Seasoned technology and venture executive join to support Epica's continued global growth and innovation strategy. LANDRUM, SC / ACCESS Newswire…